Tumors actively take up arginine via cationic amino acid transporters, as documented in the context of hepatocellular carcinoma, which bind to the RNA-binding motif protein 39 (RBM39) for further metabolic reprogramming. The gene discussed is RBM39; the disease is hepatocellular carcinoma.